Literature DB >> 9066736

Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas.

S Izumoto1, N Arita, T Ohnishi, S Hiraga, T Taki, N Tomita, M Ohue, T Hayakawa.   

Abstract

Microsatellite instability has been reported in familial cancer syndrome and in various kinds of human sporadic tumors. We investigated the replication error (RER) and mutation rate of the transforming growth factor-beta type II receptor (TGF-beta RII) gene to determine the frequency of the RER+ phenotype and elucidate the relation between the mutation of the TGF-beta RII gene and RER in the tumorigenesis of glioma. We screened genomic DNA from 40 gliomas, comprised from 24 glioblastomas (GB), 11 anaplastic astrocytomas (AA) and five astrocytomas (AS) and compared the results with DNA from corresponding leukocytes. Seven of the 40 (18%) gliomas had the RER+ phenotype: five (21%) of 24 GB and two (18%) of 11 AA. In six gliomas we detected mutation of the TGF-beta RII gene. Five (71%) of seven RER+ and one (3%) of 33 RER-tumors had one A deletion in the (A)10 repeat of the TGF-beta RII gene. No mutations were detected in the (GT)3 repeat area of the TGF-beta RII gene. As the normal cells of these glioma patients had no mutations, we concluded that the mutations were somatic. We posit that the observed mutations inactivate the receptor through a frameshift mutation resulting in protein truncation. Our data suggest that the TGF-beta RII (A)10 repeat may be one area of genomic instability in the early stages of malignant glioma tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9066736     DOI: 10.1016/s0304-3835(96)04583-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.

Authors:  M A Lynch; T A Petrel; H Song; T J Knobloch; B C Casto; D Ramljak; L M Anderson; V DeGroff; G D Stoner; R W Brueggemeier; C M Weghorst
Journal:  Gene Expr       Date:  2001

2.  Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma.

Authors:  Huafeng Wei; Pu Liu; Elizabeth Swisher; Yuen Yee Yip; Jee Hang Tse; Kathy Agnew; Karl Erik Hellström; Ingegerd Hellström
Journal:  J Immunother       Date:  2012-04       Impact factor: 4.456

3.  Transforming growth factor-β in stem cells and tissue homeostasis.

Authors:  Xin Xu; Liwei Zheng; Quan Yuan; Gehua Zhen; Janet L Crane; Xuedong Zhou; Xu Cao
Journal:  Bone Res       Date:  2018-01-31       Impact factor: 13.567

4.  Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas.

Authors:  S Lescop; A Lellouch-Tubiana; G Vassal; C Besnard-Guerin
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

5.  Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays.

Authors:  Wenling Zhang; Zhaoyang Zeng; Songqing Fan; Jieru Wang; Jianbo Yang; Yanhong Zhou; Xiayu Li; Donghai Huang; Fang Liang; Minghua Wu; Ke Tang; Li Cao; Xiaoling Li; Wei Xiong; Guiyuan Li
Journal:  J Mol Histol       Date:  2012-03-06       Impact factor: 2.611

Review 6.  TGF-β Family Signaling in Tumor Suppression and Cancer Progression.

Authors:  Joan Seoane; Roger R Gomis
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

Review 7.  Angiogenesis factors in gliomas: a new key to tumour therapy?

Authors:  Rolf Mentlein; Janka Held-Feindt
Journal:  Naturwissenschaften       Date:  2003-07-29

Review 8.  Roles of Smad3 in TGF-beta signaling during carcinogenesis.

Authors:  Caroline Millet; Ying E Zhang
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2007       Impact factor: 1.807

9.  Microsatellite instability and mutation of DNA mismatch repair genes in gliomas.

Authors:  S Y Leung; T L Chan; L P Chung; A S Chan; Y W Fan; K N Hung; W K Kwong; J W Ho; S T Yuen
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

10.  Changes in expression, and/or mutations in TGF-beta receptors (TGF-beta RI and TGF-beta RII) and Smad 4 in human ovarian tumors.

Authors:  Marie Lue Antony; Rema Nair; Paul Sebastian; Devarajan Karunagaran
Journal:  J Cancer Res Clin Oncol       Date:  2010-03       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.